Assertio Holdings, Inc.

Healthcare

NASDAQ:ASRT · NASDAQ Capital Market

Market Cap $151.73M Beta 0.53 P/E (TTM) -4.2

$23.48 +0.04%

+$0.01 today

52W Low $8.61High $23.50

Vol 0.49M · Avg 0.33M

EPS (TTM)-$5.55

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+147.68%

Period High

$23.48

Period Low

$9.07

Latest

$23.48

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Fortress Biotech, Inc.

NASDAQ:FBIO

$92.02M

XBiotech Inc.

NASDAQ:XBIT

$71.34M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$59.20M

Pulmonx Corporation

NASDAQ:LUNG

$57.86M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$55.71M

InterCure Ltd.

INCR

$47.79M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$46.70M

Nutriband Inc.

NTRB

$41.21M

Lite Strategy, Inc.

LITS

$25.22M

What is the latest ASRT filing?

The latest filing shown is SC 13G/A dated Jun 2, 2026.

How many recent filings does ASRT have?

Intrinsic Alpha currently shows 20 recent filings for ASRT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.